This shareable PDF can be hosted on any platform or network and is fully compliant with publisher copyright.
This publication has not yet been explained in plain language by the author(s). However, you can still read the publication.
If you are one of the authors, claim this publication so you can create a plain language summary to help more people find, understand and use it.
This page is a summary of: The South African Guidelines for Pharmacoeconomic Submissions’ Evidence Requirements Compared with Other African Countries and The National Institute for Health and Care Excellence in England, Expert Review of Pharmacoeconomics & Outcomes Research, May 2019, Taylor & Francis,
DOI: 10.1080/14737167.2019.1615451.
You can read the full text:
The following have contributed to this page
